STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $717,000 | -7.0% | 64,600 | -22.9% | 0.06% | -11.1% |
| Q2 2017 | $771,000 | -35.0% | 83,785 | -39.6% | 0.06% | -35.7% |
| Q1 2017 | $1,187,000 | -10.3% | 138,785 | +12.1% | 0.10% | -20.3% |
| Q4 2016 | $1,324,000 | +28.9% | 123,785 | +30.6% | 0.12% | +29.5% |
| Q3 2016 | $1,027,000 | +60.0% | 94,785 | 0.0% | 0.10% | +25.0% |
| Q2 2016 | $642,000 | +45.2% | 94,785 | 0.0% | 0.08% | +22.6% |
| Q1 2016 | $442,000 | -22.7% | 94,785 | +46.3% | 0.06% | -30.3% |
| Q3 2015 | $572,000 | -2.9% | 64,785 | +29.6% | 0.09% | -2.2% |
| Q2 2015 | $589,000 | -18.6% | 50,000 | 0.0% | 0.09% | -9.0% |
| Q1 2015 | $724,000 | – | 50,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |